Advanced Accelerator Applications International SA

Recruiter
Advanced Accelerator Applications International SA

Advanced Accelerator Applications, S.A., a Novartis company, is an innovative radiopharmaceutical company developing, producing and commercializing molecular nuclear medicine theragnostics. AAA’s theragnostic platform is based on radiolabeling a targeting molecule with either gallium Ga 68 for diagnostic use, or lutetium Lu 177 for therapy. AAA’s first theragnostic pairing for neuroendocrine tumors includes diagnostic drugs NETSPOT® in the US and SomaKit TOC® in Europe; and therapeutic Lutathera® (USAN: lutetium Lu 177 dotatate/INN: lutetium (177Lu) oxodotreotide). Additional theragnostic pairings in development target diseases such as prostate cancer, breast cancer, colorectal cancer, lung cancer, and gastrointestinal stromal tumors (GIST). AAA is also an established leader in molecular nuclear diagnostic radiopharmaceuticals for PET and SPECT, mainly used in clinical oncology, cardiology and neurology. Headquartered in Saint-Genis-Pouilly, France, AAA currently has 20 production and R&D facilities, and more than 800 employees in 13 countries (France, Italy, the UK, Germany, Switzerland, Spain, Poland, Portugal, The Netherlands, Belgium, Israel, the US and Canada).

Email me jobs from this recruiter
Get new jobs for this search by email

When you create this job alert we will email you a selection of jobs matching your criteria. Our Terms and Conditions and Privacy Policy apply to this service.

Other marketing communication

We'd love to send you information about jobs and service updates from CareersinCyber.com and the CareersinAudit Group by email.


We do not share your information with third parties for marketing purposes.
All emails will contain a link in the footer to enable you to unsubscribe at any time.